Literature DB >> 7555469

Muscle sympathetic nerve activity is higher in intensively versus conventionally treated IDDM subjects.

R P Hoffman1, C A Sinkey, E A Anderson.   

Abstract

OBJECTIVE: To determine whether poor long-term glycemic control may play a role in the lower muscle sympathetic nerve activity (MSNA) levels in insulin-dependent diabetes mellitus (IDDM). RESEARCH DESIGN AND METHODS: Intraneural electrodes were used to record MSNA from the peroneal nerve at baseline and during euglycemic insulin infusion (120 mU.m-2.min-1) in 16 IDDM subjects enrolled in the Diabetes Control and Complications Trial (DCCT), 8 intensively treated (HbA1c 7.1 +/- 1.2%) and 8 conventionally treated (HbA1c 9.0 +/- 1.5%; P < 0.05).
RESULTS: Fasting plasma glucose levels tended to be higher at baseline in the conventionally treated group (11.3 +/- 1.7 mmol/l) than in the intensively treated group (7.4 +/- 1.1 mmol/l, P < 0.1), but did not differ during insulin infusion (conventional, 5.0 +/- 0.3 mmol/l; intensive, 5.1 +/- 0.4 mmol/l). Plasma free insulin levels did not differ between groups either before or during insulin infusion. The intensively treated group had significantly high MSNA levels than the conventionally treated group both in the fasting state (16.2 +/-2.7 vs 10.5 +/- 4.4 bursts/min, P < 0.05 and during insulin infusion with euglycemia (27.8 +/- 2.1 vs 17.5 +/- 5.2 bursts/min.
CONCLUSIONS: MSNA levels in intensively treated IDDM subject are higher than in conventionally treated subjects. These results suggest that improved long-term glycemic control is associated with increased sympathetic neural outflow to muscle. The mechanism for this effect remains unclear.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7555469     DOI: 10.2337/diacare.18.3.287

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  2 in total

1.  Sustained hyperglycaemia increases muscle blood flow but does not affect sympathetic activity in resting humans.

Authors:  P J van Gurp; G A Rongen; J W M Lenders; A K M Al Nabawy; H J L M Timmers; C J Tack
Journal:  Eur J Appl Physiol       Date:  2004-11-25       Impact factor: 3.078

2.  Different Responses of Muscle Sympathetic Nerve Activity to Dapagliflozin Between Patients With Type 2 Diabetes With and Without Heart Failure.

Authors:  Takuto Hamaoka; Hisayoshi Murai; Tadayuki Hirai; Hiroyuki Sugimoto; Yusuke Mukai; Oto Inoue; Shinichiro Takashima; Takeshi Kato; Shigeo Takata; Soichiro Usui; Kenji Sakata; Masa-Aki Kawashiri; Masayuki Takamura
Journal:  J Am Heart Assoc       Date:  2021-10-30       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.